Shuchai Zhu

机构：Hebei Medical University, Fourth Hospital of Hebei Medical University · ORCID：0000-0003-0787-3325

发表论文 53 篇 · 总被引 210 次 · h-index 8

代表论文

• High-Dose Versus Standard-Dose Intensity-Modulated Radiotherapy With Concurrent Paclitaxel Plus Carboplatin for Patients With Thoracic Esophageal Squamous Cell Carcinoma: A Randomized, Multicenter, Open-Label, Phase 3 Superiority Trial (2022 · International Journal of Radiation Oncology*Biology*Physics · 被引 42)
• Irradiation-induced exosomal HMGB1 to confer radioresistance via the PI3K/AKT/FOXO3A signaling pathway in ESCC (2022 · Journal of Translational Medicine · 被引 33)
• HMGB1 induces radioresistance through PI3K/AKT/ATM pathway in esophageal squamous cell carcinoma (2022 · Molecular Biology Reports · 被引 19)
• Elective nodal irradiation provides a superior therapeutic modality for lymph node positivity esophageal squamous cell carcinoma patients receiving definitive radiotherapy versus involved-field irradiation (2019 · Medicine · 被引 17)
• Knockdown of FAM83D Enhances Radiosensitivity in Coordination with Irradiation by Inhibiting EMT via the Akt/GSK-3β/Snail Signaling Pathway in Human Esophageal Cancer Cells (2020 · OncoTargets and Therapy · 被引 15)
• Immune checkpoint inhibitors combined with or without radio(chemo)therapy for locally advanced or recurrent/metastatic esophageal squamous cell carcinoma (2023 · Discover Oncology · 被引 11)